chronic pain: role of tricyclic antidepressants, dolsulepin
TRANSCRIPT
Chronic pain: Core concepts and TCAs
DR SUDHIR KUMAR MD (Med) DM (Neuro)CONSULTANT NEUROLOGISTAPOLLO HOSPITALS, KUKATPALLY/JUBILEE HILLS (HYDERABAD)
Consensus statement on Role of tricyclic Antidepressants in chronic neuropathic pain In India Endorsed by Indian society for the study of pain (Indian chapter for the study of chronic pain)
Existing Guidelines in Neuropathic Pain
Mechanism and Pharmacokinetics of Tricyclic Antidepressants: The Number Needed to Treat and Number Needed to Harm
Current Status of Tricyclic Antidepressants in Tension-type Headache.
Adverse Effects of Tricyclic Antidepressants
Tricyclic Antidepressants in Cancer Pain and Chemotherapy-induced Neuropathic Pain
Tricyclic Antidepressants in Painful Polyneuropathy
Persistent Idiopathic Facial Pain and
Trigeminal Neuralgia
Central Neuropathic Pain Syndromes
Current Status of Tricyclic Antidepressants in Post-surgical, Post-traumatic and Phantom Limb Pain
Drug Interactions of Tricyclic Antidepressants with Various Other Analgesics used in Chronic Pain and Cancer Pain
1
2
3
4
5
6
7
8
9
10
Salient Features Mentioned in the Guidelines
Objectives
To effectively and responsibly prescribe TCAs and enhance the quality of life, in patients of chronic neuropathic pain in India
Tricyclic antidepressants is one of the foremost and first-line Therapies being prescribed for management of chronic neuropathic pain across the globe
But there are no current best practice drug status Guidelines on TCA drug class in India, and hence this is an initiative To put a consensus-based review on the same, with regard to pain practices in India
Introduction
Kodiath MF. A Comparative Study of Patients with Chronic Pain in India and the United States. Clin Nurs Res August 1992 vol. 1 no. 3 278-291
Pain is the most frequently reported symptom in the health care industry todayChronic pain in the US costs millions of dollars annually, and its financial impact is mountingAffects nearly all normal activities and often leaves the person feeling helpless and hopeless
Pain: Good or bad ? Not all pain is a disease
Protector to us most of the time.
Acute pain constitutes a signal to a conscious brain about the presence of noxious stimuli and/or ongoing tissue damage.
This acute pain signal is useful and adaptive, warning the individual of danger and the need to escape or seek help.
JL Henry. The need for knowledge translation in chronic pain. Pain Res Manage 2008;13(6):465-476.
Chronic pain as a disease !
Pain is a major healthcare problem worldwide. Although acute pain may reasonably be considered a symptom of disease or injury, chronic and recurrent pain is a specific healthcare problem, a disease in its
own right- The European Federation of International
Association for the Study of Pain Chapters
Chronic pain - Definition
Smith BH. Chronic pain in primary care. Fam Pract. 1999 Oct;16(5):475-82.
The International Association for the Study of Pain (IASP) defines pain as ‘an unpleasant sensory and emotional experience with actual or potential tissue damage or described by patients in terms of such damage’
The IASP defines chronic pain as ‘pain which has persisted beyond normal tissue healing time’, taken in the absence of other criteria, to be 3 months
Chronic pain - Prevalence In a random survey of 2012 Canadians, chronic pain was
reported by 29% of respondents, with increased frequency in women and older age groups.
The average duration of pain was 10.7 years
The average intensity was 6.3 on a 10-point scale
Almost 70% of those reporting pain were worried about addiction
Moulin DE, Clark AJ, Speechley M, Morley-Forster PK. Chronic pain in Canada – prevalence, treatment, impact and the role of opioid analgesia. Pain Res Manage 2002;7:179-84.
Chronic pain - Causes Chronic pain can arise from sundry causes. Some of the more common types of chronic pain include those of
Osteoarthritis, rheumatoid arthritis Low back Shoulder and neck Headache (including migraine) Myofascial pain syndromes Chronic regional pain syndromes Stump and phantom limb pain Neuropathic pain, herpes zoster (shingles) and postherpetic neuralgia,
trigeminal neuralgia Diabetic neuropathy Chronic visceral pain syndromes, and others.
JL Henry. The need for knowledge translation in chronic pain. Pain Res Manage 2008;13(6):465-476.
Chronic Pain - PathophysiologyThe mediators of pain
H+ K+ Substance P Bradykinin 5HT Phospholipids &
Prostaglandins
Harrison's Principles of Internal Medicine (17th Edition).New York, NY, USA: McGraw-Hill Professional Publishing, 2008.
Pain transmission and modulatory pathways
Harrison's Principles of Internal Medicine (17th Edition).New York, NY, USA: McGraw-Hill Professional Publishing, 2008.
A. Transmission system for nociceptive messages.
B. Pain-modulation network
Ascending pain pathways
Circuit of pain modulatory pathway.
Marks DM. Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise. Current Neuropharmacology, 2009, 7, 331-336
Chronic pain processes
Neurogenic inflammation
Damaged nerve
Sensitization
Loss of nociceptive control
Mental overloadWhitten, Christine, MD, Donovan, Marilee, RN, PhD, Cristobal, Kristene, MS. Treating Chronic Pain: New Knowledge, More Choices. Clinical Contributions. The Permanente Journal. Fall 2005. Vol. 9. No. 4. Retrieved: January 15, 2006 from: http://xnet.kp.org/permanentejournal/fall05/pain3.html.
Chronic pain mechanisms
Whitten, Christine, MD, Donovan, Marilee, RN, PhD, Cristobal, Kristene, MS. Treating Chronic Pain: New Knowledge, More Choices. Clinical Contributions. The Permanente Journal. Fall 2005. Vol. 9. No. 4. Retrieved: January 15, 2006 from: http://xnet.kp.org/permanentejournal/fall05/pain3.html.
Factors that increase pain
Physical
Chemical
Behavioural
Thoughts and emotions
Structural
Whitten, Christine, MD, Donovan, Marilee, RN, PhD, Cristobal, Kristene, MS. Treating Chronic Pain: New Knowledge, More Choices. Clinical Contributions. The Permanente Journal. Fall 2005. Vol. 9. No. 4. Retrieved: January 15, 2006 from: http://xnet.kp.org/permanentejournal/fall05/pain3.html.
Viscous cycle of pain
Whitten, Christine, MD, Donovan, Marilee, RN, PhD, Cristobal, Kristene, MS. Treating Chronic Pain: New Knowledge, More Choices. Clinical Contributions. The Permanente Journal. Fall 2005. Vol. 9. No. 4. Retrieved: January 15, 2006 from: http://xnet.kp.org/permanentejournal/fall05/pain3.html.
Chronic pain: Consequences
Immobility and consequent wasting of muscle, joints, etc
Depression of the immune system and increased susceptibility to disease,
Fatigue, disturbed sleep,
Poor appetite and nutrition
Dependence on medication
Overdependence on family and other caregivers
JL Henry. The need for knowledge translation in chronic pain. Pain Res Manage 2008;13(6):465-476.
– Overuse and often inappropriate use of professional health care systems
– Poor performance on the job or inability to work
– Disability
– Isolation from society and family; and turning inwards
– Anxiety, fear, bitterness, frustration, depression and suicide
Often sets the stage for the emergence of a complex set of physical and psychosocial changes
Chronic Pain: Mx
Patient evaluation
Multimodal or multidisciplinary pain management programs
Single Modality Interventions
Practice Guidelines for Chronic Pain Management. Anesthesiology 2010; 112:810 –33
Patient evaluation
1. Medical records review or patient condition2. Physical examination3. Psychological and behavioral evaluation4. Interventional diagnostic procedures
Diagnostic facet joint block Diagnostic sacroiliac joint block Diagnostic nerve block (e.g., peripheral or sympathetic, medial
branch, celiac plexus, and hypogastric). Provocative discography
Practice Guidelines for Chronic Pain Management. Anesthesiology 2010; 112:810 –33
Multimodal pain management programs Multimodal interventions - use of more than one type of
therapy for the care of patients with chronic pain.
Multidisciplinary interventions - multimodality approaches in the context of a treatment program that includes more than one discipline.
Effective in reducing the intensity of pain reported by patients for periods of time ranging from 4 months to 1 yr
Practice Guidelines for Chronic Pain Management. Anesthesiology 2010; 112:810 –33
Single Modality Interventions Ablative techniques Acupuncture Blocks Botulinum toxin Electrical nerve stimulation Epidural steroids with or without local anesthetics Intrathecal drug therapies Minimally invasive spinal procedures Pharmacologic management Physical or restorative therapy Psychological treatment
Practice Guidelines for Chronic Pain Management. Anesthesiology 2010; 112:810 –33
Pain and DepressionCause or effect? A growing body of literature has focused on the
interaction between depression and pain symptoms.
Labeled by some authors as the depression-pain syndrome or depression- pain dyad, implying that The conditions often coexist Respond to similar treatments, Exacerbate one another, and Share biological pathways and neurotransmitters.
Bair MJ. Depression and pain comorbidity. Arch Intern Med. 2003;163:2433-2445
Pain and DepressionSome questions to be answered…… What is the prevalence of pain symptoms in patients
with depression and, conversely, what is the prevalence of depression in patients with pain complaints?
Does the presence of pain affect provider recognition and treatment of depression?
Does the presence of pain affect depression outcomes such as functional limitations, quality of life, health care costs and utilization, and treatment efficacy?
Bair MJ. Depression and pain comorbidity. Arch Intern Med. 2003;163:2433-2445
Pain and DepressionSome questions to be answered…… Does the presence of depression affect these same
clinical outcomes in patients treated for pain?
Is antidepressant treatment for painful symptoms and comorbid depression effective?
What are the common biological pathways and implications for treatment choice when depression and pain coexist?
Bair MJ. Depression and pain comorbidity. Arch Intern Med. 2003;163:2433-2445
What is the prevalence of pain symptoms in patients with depression? The prevalence of pain ranged from 15% to 100%
(mean prevalence, 65%).Pain symptoms in patients with depression
69
51
85
59 59 56
41
65
43
0102030405060708090
1
Patie
nts
with
pai
n %
Primary care Psychiatric inpatients Neurology clinic
Outpatient clinic Private practice Psychiatric patients
Psychiatric patients Depressed outpatients General practiceBair MJ. Depression and pain comorbidity. Arch Intern Med. 2003;163:2433-2445
What is the prevalence of pain symptoms in patients with depression? Depressive symptoms predict future episodes of low
back pain, neck-shoulder pain, and musculoskeletal symptoms
Low back pain is more than 2 times as likely to be reported by individuals with depressive symptoms
Specific complaints of headache, abdominal pain, joint pain, and chest pain are frequently reported by patients with depression in primary care settings and by elderly nursing home residents.
Bair MJ. Depression and pain comorbidity. Arch Intern Med. 2003;163:2433-2445
What is the prevalence of depression in patients with pain complaints? Several reviews have examined the prevalence of major depression
in patients with pain.Prevalence rates for concurrent depression in patients with pain
52
38
56
85
1318
27
0102030405060708090
1
Patie
nts
with
dep
ress
ion
%
Pain clinics Psychiatric clinics Orthopedic clinics
Dental clinics Gynecology clinics Population based settings
Primary care clinics
Bair MJ. Depression and pain comorbidity. Arch Intern Med. 2003;163:2433-2445
What is the prevalence of depression in patients with pain complaints? Patients with multiple pain symptoms are 3 to 5 times
more likely to be depressed than patients without pain
Subjects with chronic pain are 3 times as likely to meet depression criteria as those without chronic pain.
An international study - patients with pain lasting longer than 6 months were more than 4 times as likely to have a depressive disorder as those without chronic pain.
Bair MJ. Depression and pain comorbidity. Arch Intern Med. 2003;163:2433-2445
Does the presence of pain affect provider recognition and treatment of depression? More than 50% of patients with depression report somatic
complaints only.
At least 60% of these somatic complaints are pain related.
Patients with depression in primary care settings are more likely to report various pain symptoms
The patient’s presentation of physical complaints (and the prominence of pain symptoms) interferes with the recognition of depression for patients in primary care settings.
Bair MJ. Depression and pain comorbidity. Arch Intern Med. 2003;163:2433-2445
Does the presence of pain affect depression outcomes? Presence of up to 5 different pain complaints is associated
with increased symptoms of depression.
Progressive pain severity at baseline is associated with Poor depression outcomes, including more severe depression More pain related functional limitations Worse self-rated health Higher unemployment rate More frequent use of opioid analgesics, and More frequent pain-related doctor visits
Bair MJ. Depression and pain comorbidity. Arch Intern Med. 2003;163:2433-2445
Does the presence of depression affect clinical outcomes in patients treated for pain? Depression is associated with an array of poor pain
outcomes and worse prognosis.
Patients with pain and comorbid depression experience More pain complaints More intense pain, More amplification of pain symptoms, and Longer duration of pain.
Unfortunately patients with both conditions were more likely to have persistent pain and nonrecovery.
Bair MJ. Depression and pain comorbidity. Arch Intern Med. 2003;163:2433-2445
Is antidepressant treatment for painful symptoms and comorbid depression effective?
Source No. of patients
Sample Medication OutcomePain Depression
Blumer et al 104 Chronic pain TCA 57% improved
Improved
Hill and Blendis
27 Non-organic abdominal pain
TCA 100% improved
100% improved
Singh and Verma
60 Pain, no etiology
TCA 80% improved
Improved
Ward et al 36 Chronic back pain
TCA 50% improved
70% improved
Bair MJ. Depression and pain comorbidity. Arch Intern Med. 2003;163:2433-2445
Common biological pathways when depression and pain coexist? Common link between pain and depression could be
associated with two neurotransmitters, 5-HT and NE.
Both serotonergic and norepinergic pathways from the brainstem ascend into the brain and mediate numerous emotional and physical functions.
They also descend down the spinal cord where they suppress nociceptive inputs
Williams LJ. Depression and pain: an overview. Acta Neuropsychiatrica 2006: 18:79–87.
Antidepressants for chronic pain ! Have a genuine analgesic action
The analgesic efficacy is without any effect on mood in depressed chronic-pain patients
The dose required to achieve an optimum analgesic response is usually lower than that required to achieve an antidepressant effect
Variation exists in analgesic efficacy among chemical classes
Mico JA. Antidepressants and pain. Trends Pharmacol Sci. 2006 Jul;27(7):348-54.
Analgesic MOA of antidepressants
Verdu et al. Antidepressants for the Treatment of Chronic Pain. Drugs 2008; 68 (18): 2611-2632
Tricyclic antidepressants, produce spinally and supraspinally mediated analgesia in chronic pain states by
mechanisms distinct from those that enhance mood
Analgesic MOA of TCAs
The various mechanisms of TCAs identified and reported for their analgesic activity are as follows: Potentiation of the suppressant effect of adenosine on central
neurons.
Blockade of alpha-2 adrenoceptors leading to increased accumulation of catecholamines (Nor-epinephrine).
Inhibition of reuptake of monoamines (noradrenaline, serotonin) in the neurons of the central nervous system.
Potentiation of the actions of biogenic amines in the central nervous system by blockade of their major means of physiological inactivation-reuptake at nerve terminals.
Panda P. Antinociceptive Property of Tricyclic Antidepressants – A Review. International Journal of Research in Pharmaceutical and Biomedical Sciences. 2011. 2(2); 345-50
TCAs Vs SSRIs
The well known TCAs have the greatest analgesic efficacy
When TCAs are used as analgesic drugs, their undesirable effects occur less commonly and are less severe
SSRIs provide less consistent analgesia as compared to TCAs
Mico JA. Antidepressants and pain. Trends Pharmacol Sci. 2006 Jul;27(7):348-54.
Comparative analgesic efficacy
Antidepressants No. of human studies NNT
TCA 23 3.1
SSRI 3 6.8
SNRI 3 5.5
Mico JA. Antidepressants and pain. Trends Pharmacol Sci. 2006 Jul;27(7):348-54.
TCAs in treatment of chronic pain
The TCAs are extremely useful for the management of patients with chronic pain.
Analgesic effect of TCAs has a more rapid onset and occurs at a lower dose than is typically required for the treatment of depression.
Furthermore, patients with chronic pain who are not depressed obtain pain relief with antidepressants.
There is evidence that tricyclic drugs potentiate opioid analgesia.
Harrison's Principles of Internal Medicine (17th Edition).New York, NY, USA: McGraw-Hill Professional Publishing, 2008.
Painful conditions that respond to TCAs Post herpetic neuralgia
Diabetic neuropathy
Tension headache
Migraine headache
Rheumatoid arthritis
Chronic low back pain
Harrison's Principles of Internal Medicine (17th Edition).New York, NY, USA: McGraw-Hill Professional Publishing, 2008.c
American Pain Society and American College of Physicians
In low back pain (LBP), TCAs have been the most frequently-tested antidepressants
TCAs are effective for pain relief in LBP.
Their analgesic effect has been reported to be similar to that of NSAIDs.
Dharmshaktu. Efficacy of Antidepressants as Analgesics: A Review. J Clin Pharmacol published online 17 March 2011
Pearls for practice
Pain has traditionally been seen as secondary to something else –the result is undertreated or untreated pain, unnecessary suffering, heavier reliance on the health care system, loss of productivity in the work force, absenteeism, increased comorbidity, and a cycle of illness
Total pain alleviation is the prime goal of pain management
Management of any form of persistent pain requires not only a reduction in pain intensity but also improvement of quality of life
Pearls for practice
TCAs are extremely useful for the management of patients with chronic pain
American Pain Society and American College of Physicians guidelines state that TCAs are effective for pain relief in low back pain
Dosulepin/Dotheipin
Chemical structure of Dothepin Chemical structure of Amitriptylline
Dosulepin is a Thio-analouge of amitriptyline.
Superiority of Dosulepin over Amitriptylline
Better tolerated than Amitriptyline
Well tolerated in geriatric patients with no cardiac toxicity
No changes in electrocardiophysiology
Khan A.A study of dothiepin hydrochloride in elderly patients with special reference to cardio vascular system. Modern geriatrics august 1975
Efficacy Of Prothiaden In Depression In Rheumatoid Arthritis
A phase IV, open, single arm, prospective study was initiated with dothiepin hydrochloride
Dothiepin 75 mg/day for 6 weeks
Results: 25 Rheumatoid arthritis patients suffering from co-morbid MDD completed the 6-week dothiepin hydrochoride treatment and were considered for final analysis
49
Efficacy Of Prothiaden In Depression In Rheumatoid Arthritis
0
10
20
30
40
50
60
70
80
MarkedImprovement
ModerateImprovement
0
10
20
30
40
50
60
70
80
Good Fair
Per
cent
age
Per
cent
age
Global impression of efficacy at 6 weeks
ASSESSMENTIMPROVEMENT
Overall Assessment of Tolerability
50
CONCLUSIONS
Chronic pain is common in our practice. Depression and chronic pain often co-exist Tricyclic antidepressant especially Dothiepin is very effective
in chronic pain reduction Dothiepin is well tolerated and there are no serious adverse
effects Dothiepin treatment is cost-effective too.
Knowing is not enough; we must apply.Willing is not enough; we must do.
– Goethe
Thank You [email protected]://bestneurodoctor.blogspot.in/http://www.facebook.com/bestneurologist/